Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

          - [Release No. 34-83388; File No. SR-CboeBZX-2017-006]

                    On November 21, 2017, Cboe BZX Exchange, Inc. (“Exchange” or “BZX”) filed with the Securities and Exchange Commission (“Commission”), pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (“Act”) [1]                                          and Rule 19b-4 thereunder,[2]                                          a proposed rule change to list and trade shares (“Shares”) of series of the Cboe Vest S&P 500® Enhanced Growth Strategy ETF under Exchange Rule 14.11(c)(3), which governs the listing and trading of Index Fund Shares. The proposed rule change was published for comment in the                     **Federal Register**                     on December 11, 2017.[3]                                          On January 19, 2018, the Commission extended the time period within which to approve the proposed rule change, disapprove the proposed rule change, or institute proceedings to determine whether to approve or disapprove the proposed rule change.[4]                                          On March 9, 2018, the Commission initiated proceedings to determine whether to disapprove the proposed rule change.[5] 

                    On April 13, 2018, the Exchange filed Amendment No. 1 to the proposed rule change.[6]                                          The Commission has received no comments on the proposed rule change.                

                    Section 19(b)(2) of the Act [7]                                          provides that, after initiating disapproval proceedings, the Commission shall issue an order approving or disapproving the proposed rule change not later than 180 days after the date of publication of notice of the filing of the proposed rule change. The Commission may extend the period for issuing an order approving or disapproving the proposed rule change, however, by not more than 60 days if the Commission determines that a longer period is appropriate and publishes the reasons for such determination. The proposed rule change was published for notice and comment in the                     **Federal Register**                     on December 11, 2017. June 9, 2018, is 180 days from that date, and August 8, 2018, is 240 days from that date.                

                    The Commission finds it appropriate to designate a longer period within which to issue an order approving or disapproving the proposed rule change so that it has sufficient time to consider the proposed rule change, as modified by Amendment No. 1. Accordingly, pursuant to Section 19(b)(2) of the Act,[8]                                          the Commission designates August 8, 2018, as the date by which the Commission shall either approve or disapprove the proposed rule change (File No. SR-CboeBZX-2017-006), as modified by Amendment No. 1.                

                        For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.[9] 

Eduardo A. Aleman,

Assistant Secretary.

# Footnotes

1.                             15 U.S.C. 78s(b)(1).                    
        Back to Citation      

2.                             17 CFR 240.19b-4.                    
        Back to Citation      

3.                                                     *See*                         Securities Exchange Act Release No. 82216 (December 5, 2017), 82 FR 58235.                    
        Back to Citation      

4.                                                     *See*                         Securities Exchange Act Release No. 82552, 83 FR 3819 (January 26, 2018).                    
        Back to Citation      

5.                                                     *See*                         Securities Exchange Act Release No. 82843, 83 FR 11264 (March 14, 2018).                    
        Back to Citation      

6.                             In Amendment No. 1, which amended and replaced the proposed rule change in its entirety, the Exchange: (a) Clarified the requirements and applicability of BZX Rule 14.11(c)(3) as it pertains to the Shares; (b) supplemented its description of the indexes; (c) supplemented its description of outcome periods; (d) clarified its assertions relating to susceptibility of manipulation of the Shares; (e) made certain corrections to maintain consistency with defined terms; (f) provided a description of the suitability requirements with respect to Exchange members; and (g) made other technical and non-substantive corrections and updates. Because Amendment No. 1 does not materially alter the substance of the proposal or raise unique or novel regulatory issues, Amendment No. 1 is not subject to notice and comment. Amendment No. 1 is available at:                         *https://www.sec.gov/​comments/​sr-cboebzx-2017-006/​cboebzx2017006-3458512-162202.pdf.*
        Back to Citation      

7.                             15 U.S.C. 78s(b)(2).                    
        Back to Citation      

8.                                                     *Id.*
        Back to Citation      

9.                                 17 CFR 200.30-3(a)(57).                        
        Back to Citation      

[FR Doc. 2018-12552 Filed 6-11-18; 8:45 am]

 BILLING CODE 8011-01-P